CN Patent

CN105120864B — 表现出抗癌活性和抗增殖活性的2‑氨基嘧啶‑6‑酮及类似物

Assigned to Deciphera Pharmaceuticals LLC · Expires 2017-05-17 · 9y expired

What this patent protects

本发明描述式I的化合物，其可通过抑制c‑FMS(CSF‑IR)、c‑KIT和/或PDGFR激酶用于治疗癌症、自身免疫疾病和骨代谢病症。这些化合物还可用于治疗由c‑FMS、c‑KIT或PDGFR激酶介导的其它哺乳动物疾病。

USPTO Abstract

本发明描述式I的化合物，其可通过抑制c‑FMS(CSF‑IR)、c‑KIT和/或PDGFR激酶用于治疗癌症、自身免疫疾病和骨代谢病症。这些化合物还可用于治疗由c‑FMS、c‑KIT或PDGFR激酶介导的其它哺乳动物疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN105120864B
Jurisdiction
CN
Classification
—
Expires
2017-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Deciphera Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.